Contemporary Reversal of Oral Anticoagulation in Intracerebral Hemorrhage
Stroke 50:529-536, Bower, M.M.,et al, 2019
Simultaneous CMV and Listeria Infection Following Alemtuzumab Treatment for Multiple Sclerosis
Neurol 92:296-298, Pappolla, A.,et al, 2019
Acute Maternal Confusion and Neonatal Seizure Postpartum
BMJ 364:k5399, Jakes, A.D.,et al, 2019
Association of Initial Disease-Modifying Therapy with Later Conversion to Secondary Progressive Multiple Sclerosis
JAMA 32:175-187, Brown, J.W.L.,et al, 2019
Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis
JAMA 32:165-174,153, Burt, R.K.,et al, 2019
The Dangers of PRES
Neurol 92:e282-e285, Chaterine, C.,et al, 2019
Cerebral Microbleeds
Neurol 92:e253-e262, Graff-Radford, J.,et al, 2019
Central Nervous System Infections Due to Coccidioidomycosis
J Fungi 5:2-12, Jackson, N.R.,et al, 2019
Cerebellar Hippocampal and Basal Nuclei Transient Edema with Restricted Diffusion (CHANTER) Syndrome
Neurocrit Care 31:228-296, Jasne, A.S.,et al, 2019
Cerebrovascular Manifestations of Herpes Simplex Virus Infection of the Central Nervous System: A Systematic Review
J Neruoinflam 16:19, Hauer,L.,et al, 2019
IV and mechanical thrombolysis for ischemic stroke secondary to cardiac myxoma
Neurol 93:975-977, Barghouthi, T., et al, 2019
Non-Bacterial Thrombotic Endocarditis
Infective Endocarditis doi:10.5772/intechopen.84398, Busca-Arenzana, C.,et al, Chp 6, pg 315, 2019
Clinical Manifestations and Diagnosis of Nocardiosis
UptoDate May, Spelman, D., 2019
Metabolic Lipid Muscle Disorders: Biomarkers and Treatment
Ther Adv Neurol Disord 12:1-15, Angelini, C.,et al, 2019
Spontaneous Posterior Spinal Cord Infarction Presenting as Sensory Disturbance with Radiating Pain
JNN 11:178-181, Seo,J.,et al, 2019
The Etiologies and Prognosis Associate with Spinal Cord Infarction
Ann Clin Trns Neurol 6:1456-1464, Hse,j.L.,et al, 2019
Cerebral Sinovenous Thrombosis as a Compliction of Otitis Media
Clin Case Rep 7:186-188, Salloum,S. and Bezer,K., 2019
Brain Zaps: An Underappreciated Symptom of Antidepressant Discontinuation
Psychiatry.com 2018, Papp, A. & Onton, J.A., 2018
Cerebral Fat Embolism Syndrome in Sickle Cell Disease Without Evidence of Shunt
eNeurologicSci 14:19-20, Nathan, C.L.,et al, 2018
Nivolumab-Induced Autoimmune Encephalitis in Two Patients with Lung Adenocarcinoma
Case Rep Neurol Med 2018;doi:10.1155/2018/2548528, Shah, S.,et al, 2018
Vascular Wall Imaging in Reversible Cerebral Vasoconstriction Syndrome - a 3-T Contrast-Enhanced MRI Study
J Headache Pain 19:74-81, Chen, C.Y.,et al, 2018
Progressive Multifocal Leukoencephalopathy after Treatment with Nivolumab
Emerg Inf Dis 24:1594-1596, Martinot, M.,et al, 2018
Heart Transplantation in a Patient with Myotonic Dystrophy Type 1 and End-Stage Dilated Cardiomyopathy: A Short Term Follow-up
Acta Myologica 37:267-271, Papa, A.A.,et al, 2018
Delayed-Onset MRI Findings in Acute Chorea Related to Anoxic Brain Injury
Clin Imaging 48:22-25, Ghasemi, M.,et al, 2018
A Case of Bilateral Orbital Mass Lesions Presenting with Acute Monocular Vision Loss
Neurol 91:e2192-e2196, Bhatt, N.,et al, 2018
Galcanezumab in Chronic Migraine
Neurol 91:e2211-e2221, Detke, H.C.,et al, 2018
Clinical Presentation and Cranial MRI Findings of Listeria Monocytogenes Encephalitis
Neurologist 23:198-203, Arslan, F.,et al, 2018
Subacute Progressive Ptosis, Ophthalmoplegia, Gait Instability, and Cognitive Changes
JAMA Neurol 75:1284-1285, Lin, J.,et al, 2018
Coagulation Test Interpretation in a Patient Taking Direct Oral Anticoagulant Therapy
JAMA 320:1485-1486, Sholzberg, M. & Xu, Y., 2018
Lasmiditan is an Effective Acute Treatment for Migraine
Neurol 91:e2222-e2232, Kuca, B.,et al, 2018
Misdiagnosis of Multiple Sclerosis
Neurol 92:15-16, Brownlee, W.J., 2018
Tocilizumab Treatment for New Onset Refractory Status Epilepticus
Ann Neurol 84:940-945, Jun, J.,et al, 2018
Enhancing Vigilance for Detection of Cerebral Air Embolism
Neurol 91:717-720, Mirtchev, D.,et al, 2018
Switching the Manufacturer of Antiepileptic Drugs is Associated with Higher Risk of Seizures: A Nationwide Study of Prescription Data in Germany
Ann Neurol 84:918-925, Lang, J.D.,et al, 2018
Clnicopathologic Conference Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis
NEJM 379:870-878, CASE 27-2018, 2018
Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis
NEJM 379:1017-1027, Chitnis, T.,et al, 2018
Inclusion of Optic Nerve Involvement in Dissemination in Space Criteria for Multiple Sclerosis
Neurol 91:e1130-e1134,545, Brownlee, W.J.,et al, 2018
Interventions for Improving Modifiable Risk Factor Control in the Secondary Prevention of Stroke
Stroke 49:e301-e302, Bridgwood, B.,et al, 2018
Myasthenia Gravis Following Alemtuzumab Therapy for Multiple Sclerosis
Neurol 91:622-624, Midaglia, L.,et al, 2018
Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
NEJM 379:722-730,789, Tawbi, H.A.,et al, 2018
Nonconvulsive Status Epilepticus in Acute Intracerebral Hemorrhage
Stroke 49:1759-1761, Matsubara, S.,et al, 2018
Use of Imaging to Select Patients for Late Window Endovascular Therapy
Stroke 49:2256-2260, Albers, G.W., 2018
An Infant with Episodic Facial Flushing
Neurol 91:278-281, Kang,J.H.,et al, 2018
D-dimer >2.785 �g/ml and multiple infarcts =3 vascular territories are two characteristics of identifying cancer-associated ischemic stroke patients
Neurol Res 40:948-954, Wang, J.,et al, 2018
Childhood Seizures After Phototherapy
Pediatrics 142:e20180648, Newman, T.B.,et al, 2018
Facial Myokymia and Myorhythmia in Anti-IgLON5 Disease
Neurol 91:e1659, Vetter, E.,et al, 2018
Spinal Cord Infarction Because of Spontaneous Vertebral Artery Dissection
Stroke 49:e314-e317, Montalvo, M.,et al, 2018
Clinicopathologic Conference, Pulmonary Adenocarcinoma, Complicated by a Hypercoagulable State with a Nonbacterial Thrombotic Endocarditis
NEJM, Case 33-2018, 2018
Immune Checkpoint Inhibitor-Related Myositis and Myocarditis in Patients with Cancer
Neurol 91:e985-e994, Touat, M.,et al, 2018
Pembrolizumab-Induced Myasthenia Gravis
Neurol 91:e1365-e1367, Algaeed, M.,et al, 2018